// App-Quantinova.ai

PB1760 : AZACITIDINE AS TREATMENT OF KMT2A INFANT ACUTE LYMPHOBLASTIC LEUKEMIA: SINGLE CENTER EXPERIENCE

Researchers

Presenter

  • Giovanna Giagnuolo

Principal Investigators

  • Antonia De Matteo

  • Pio Stellato

  • Fara Petruzziello

  • Rosanna Cuccurullo

  • Giuliana Beneduce

  • Fabiana Cacace

  • Francesco Paolo Tambaro

  • Rosanna Parasole

  • Giuseppe Menna

Medical Centers

  • Department of Oncology,AORN Santobono-Pausilipon,Napoli,Italien

  • Department of Oncology,AORN Santobono-Pausilipon,Napoli,Italien

  • Department of Oncology,AORN Santobono-Pausilipon,Napoli,Italien

  • Department of Oncology,AORN Santobono-Pausilipon,Napoli,Italien

  • Department of Oncology,AORN Santobono-Pausilipon,Napoli,Italien

  • Department of Oncology,AORN Santobono-Pausilipon,Napoli,Italien

  • Department of Oncology,AORN Santobono-Pausilipon,Napoli,Italien

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Histone-lysine N-methyltransferase 2A

Drug/Treatment

  • Vidaza

  • Prednisone

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved